Skip to main content

Table 1 Patient characteristics

From: Validity and prognostic significance of sperm protein 17 as a tumor biomarker for epithelial ovarian cancer: a retrospective study

 

Whole cohort

Patients with tissue specimens

Patients with serum specimens

Number of specimens, n (%)

Age in years

982 (100)

943 (100)

104 (100)

 0–19

24 (2)

24 (3)

1 (1)

 20–39

133 (14)

125 (13)

16 (15)

 40–59

510 (52)

487 (52)

64 (62)

 60+

306 (31)

298 (32)

23 (22)

 Unknown

9 (1)

9 (1)

0 (0)

Normal ovary

15

15

0

Normal fallopian tube

3

3

0

Benign ovarian neoplasms

15

11

7

 Serous cystadenoma

6

6

1

 Mucinous cystadenoma

2

2

1

 Other

7

3

5

Borderline ovarian tumors

34

33

15

 Serous

26

26

9

 Mucinous

7

6

5

 Other

1

1

1

Sex cord stromal tumors

64

61

5

Germ cell tumors

49

47

2

Epithelial ovarian carcinoma

802 (100)

773 (100)

75 (100)

Grade

 1

133 (17)

132 (17)

23 (31)

 2

212 (26)

211 (27)

4 (5)

 3

437 (54)

420 (54)

48 (64)

 Unknown

20 (2)

10 (1)

0 (0)

Stage

 I

289 (36)

283 (37)

26 (35)

 II

93 (12)

91 (12)

6 (8)

 III

279 (35)

262 (34)

35 (47)

 IV

53 (7)

50 (6)

8 (11)

 Unknown or unstaged

88 (11)

87 (11)

0 (0)

Histology

 Serous

531 (66)

518 (67)

29 (39)

 Endometrioid

73 (9)

68 (8)

14 (19)

 Clear cell

58 (7)

56 (7)

8 (11)

 Mucinous

79 (10)

72 (9)

12 (16)

 Mixed/Other

61 (8)

59 (8)

12 (16)